Amira makes appointments to scientific advisory board
This article was originally published in Scrip
Executive Summary
Amira Pharmaceuticals, a US small molecule pharmaceutical company focused on the discovery and development of compounds to treat inflammatory diseases, has appointed Dr Paul Anderson, Professor Jerold Chun and Professor Andrew Tager to its scientific advisory board. Dr Anderson has more than 40 years' pharmaceutical research and managerial experience, including 30 years at Merck Research Laboratories. Dr Chun is a professor at The Scripps Research Institute in La Jolla, California, while Dr Tager is an assistant professor at Harvard Medical School in the pulmonary and critical care unit of the Massachusetts General Hospital, and co-director of the hospital's interstitial lung disease programme.